Cytokine secretion by peripheral blood mononuclear cells in myasthenia gravis

Journal of Clinical Neuroscience

Volumn 9, Issue 2, 2002, Pages 133-136

  Yoshikawa, Hiroaki ^a   Satoh, Katsuaki ^a   Yasukawa, Yoshihiro ^a   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Acetylcholine receptor antibody; IgG; Interleukin 5; Interleukin 6; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MONONUCLEAR CELL; MYASTHENIA GRAVIS; PRIORITY JOURNAL;

EID: 0036240295     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.2001.1028     Document Type: Article

References (33)

1. Myasthenia gravis
2. Acetylcholine receptors and myasthenia
3. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins
4. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation
5. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (lgG and C3), and of the acetylcholine receptor
6. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value
7. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Results in 153 validated cases and 2967 diagnostic assays
8. Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome
9. Acetylcholine receptor antibody synthesis by thymic lymphocytes: Correlation with thymic histology
10. Antibodies to acetylcholine receptor and tetanus toxoid: In vitro synthesis by thymic lymphocytes
11. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis
12. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis
13. Acetylcholine receptor autoantibody secretion by thymocytes: Relationship to myasthenia gravis
14. Upregulation of Bcl-2 protein in the myasthenic thymus
15. Altered intrathymic T-cell repertoire in human myasthenia gravis
16. Thymocyte F as expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody
17. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients
18. Cytokines and the pathogenesis of myasthenia gravis
19. Immunoglobulin production by cultured human lymphocytes
20. Analysis of immunoglobulin secretion by lymph organs with myasthenia gravis
21. Studies in myasthenia gravis. Short-term massive corticotropin therapy
22. Immunological and pharmacological heterogeneity of alpha-bungarotoxin binding sites extracted from TE671 cells
23. Measurement of proteins with the Behring Nephelometer. A multicentre evaluation
24. The role of helper T cell subsets in autoimmune diseases
25. The concept of type-1 and type-2 helper T cells and their cytokines in humans
26. Immune activation in myasthenia gravis: Soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients' serum
27. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis
28. Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis
29. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4-producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes
30. Autoimmunity, polyclonal B-cell activation and infection
31. Polyclonal B lymphocyte activation in progressive systemic sclerosis
32. Interleukin-5 production by mononuclear cells from aged individuals: Implication for autoimmunity
33. Anticytokine therapy in autoimmune diseases